Manufacturing News of Note—Samsung Bioepis, Biogen add to biosimilars; Boehringer Ingelheim to add 105 jobs in Puerto Rico

stocks
(Pixabay)

> Biogen and Samsung Bioepis are expanding their biosimilar agreement. Story

> Croatia has taken action against NCPC Hebei Huamin Pharmaceutical over manufacturing issues. EMA

> Boehringer Ingelheim’s animal health unit will invest nearly $50 million to expand a plant in Puerto Rico and expects to add 105 jobs. Release

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

> Chinese biotech Akeso Pharmaceuticals will open a new GE flex facility in Guangzhou, China. Release 

Suggested Articles

Nearly four decades after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market.

Pfizer's 1.1-million-square-foot sterile injectables plant in Visakhapatnam has been criticized by the FDA for poor quality testing.

Amidst a gung-ho shift to oncology, Daiichi is also fleshing out its gene therapy capacity with a $200 million licensing deal with Ultragenyx.